Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Biora Therapeutics Inc (BIOR)

Biora Therapeutics Inc (BIOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Biora Therapeutics Successfully Completes Restructuring Process GlobeNewswire - Mon Mar 31, 2025

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Undertakes Chapter 11 Sale Process to Position Business for Future Growth GlobeNewswire - Mon Dec 30, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Thu Nov 14, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update GlobeNewswire - Thu Nov 7, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire - Tue Oct 29, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting GlobeNewswire - Mon Oct 28, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting GlobeNewswire - Mon Oct 14, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium GlobeNewswire - Mon Oct 7, 2024

BIOR : 0.2200 (-50.01%)
Biora Therapeutics Announces Successful Completion of Device Performance Study in Ulcerative Colitis Patients for its Targeted Therapeutics Platform Globe Newswire - Wed Aug 10, 2022

All Devices Successfully Detected Colon Entry in Patients with Active Ulcerative Colitis...

BIOR : 0.2200 (-50.01%)
Biora Therapeutics to Report Second Quarter 2022 Financial Results and Provide Corporate Update Globe Newswire - Mon Aug 8, 2022

SAN DIEGO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics, today...

BIOR : 0.2200 (-50.01%)

Barchart Exclusives

Ignore the Anthropic Panic and Keep Buying Palantir Stock, Says Wedbush Barchart - Mon Apr 13, 3:53PM CDT
Wedbush urges investors to tune out the Anthropic noise and keep buying Palantir, betting on its strong AI moat and solid fundamentals. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.